BioCentury
ARTICLE | Product Development

Novavax announces high neutralizing antibody titers in COVID-19 vaccine

June 10, 2020 12:54 AM UTC

A COVID-19 candidate vaccine from Novavax has produced the highest reported levels of neutralizing titers in non-human primate studies.

“We are seeing neutralizing titers in the 10,000 range in non-human primates,” Gregory Glenn, president of R&D at Novavax Inc. (NASDAQ:NVAX), said Tuesday in a presentation to the BIO annual meeting. ...



Access The Full Article